Filatova S V, Pinegin B V, Simonova A V, Artem'ev M E, Golubeva N M
Vestn Otorinolaringol. 2001(5):26-8.
30 patients with chronic tonsillitis (CT) and 20 patients with chronic sinusitis (CS) received likopid (4 mg/day for 10 days). CT patients were additionally treated with tonsil lacunar lavage with dioxidine solution. Likopid was found effective in CT patients (good response--31%, partial response--59%). 9% did not respond to likopid. CS patients benefited less (good response--10%, partial response--50%). 40% were non-responders. In CT patients likopid demonstrated also an immunomodulating effect. Positive changes were observed in the counts of B-lymphocytes, T-lymphocytes, T-helpers, natural killers, level of serum IgG, titers of specific antibodies, functional activity of neutrophils. In CS this effect was less pronounced.
30例慢性扁桃体炎(CT)患者和20例慢性鼻窦炎(CS)患者接受了利可派(4毫克/天,共10天)治疗。CT患者还接受了用二氧嘧啶溶液进行的扁桃体隐窝灌洗。结果发现利可派对CT患者有效(良好反应——31%,部分反应——59%)。9%的患者对利可派无反应。CS患者获益较少(良好反应——10%,部分反应——50%)。40%的患者无反应。在CT患者中,利可派还表现出免疫调节作用。在B淋巴细胞、T淋巴细胞、辅助性T细胞、自然杀伤细胞计数、血清IgG水平、特异性抗体滴度、中性粒细胞功能活性方面观察到了积极变化。在CS患者中,这种作用不太明显。